• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME BIOSURGERY (SEPRAMESH) SEPRAMESH; MCN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME BIOSURGERY (SEPRAMESH) SEPRAMESH; MCN Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Emotional Changes (1831); Pain (1994); Injury (2348)
Event Type  Injury  
Event Description
Suffered permanent injuries [injury nos] emotional distress [emotional distress] significant pain and suffering [pain] diminished quality of life [general physical health deterioration] case narrative: initial information from united states received on 14-jan-2021 regarding an unsolicited valid serious case received from a lawyer (legal case).This case involves adult patient who experienced emotional distress, significant pain and suffering, suffered permanent injuries and diminished quality of life, with the use of medical device carboxymethylcellulose, polypropylene, sodium hyaluronate (sepramesh).The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.On an unknown date, the patient started using carboxymethylcellulose, polypropylene, sodium hyaluronate at unknown dose, frequency via unknown route (lot - unk) for unknown indication.On an unknown date after an unknown latency patient developed emotional distress, significant pain and suffering (pain), permanent injuries (injury), diminished quality of life (general physical health deterioration) and lost wages and earning capacity.Action taken: not applicable for all events it was not reported if the patient received a corrective treatment.The patient outcome is reported as unknown for all events a product technical complaint was initiated and the results for the same were pending.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SEPRAMESH
Type of Device
MCN
Manufacturer (Section D)
GENZYME BIOSURGERY (SEPRAMESH)
76 new york avenue
framingham 01701
Manufacturer (Section G)
GENZYME BIOSURGERY (SEPRAMESH)
76 new york avenue
framingham 01701
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
a
bridgewater 08807
MDR Report Key11206740
MDR Text Key227921322
Report Number1221601-2021-00001
Device Sequence Number1
Product Code MCN
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial
Report Date 01/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/21/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Disability;
-
-